Garuda - Garba Rujukan Digital

The Impact of Current Trends in Health Care on the Pharmaceutical Sales Force of the Future Haider, Rehan; Asghar Mehdi; Anjum Zehra; Geetha Kumari Das; Zameer Ahmed; Sambreen Zameer
International Journal of Natural and Health Sciences Vol. 2 No. 2 (2024): April 2024
Publisher : MultiTech Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.59890/ijnhs.v2i2.1260

Drug manufacturing is undergoing a life-changing development compelled by current flows in healthcare. This abstract explores the deep impact of these styles on the drug auction force of the future. The convergence of science, switching healthcare examples, and developing patient expectations is changing the countryside at which point drug companies run. One main style is the growing focus on embodied cures and point-in-direction therapies. Advances in genomics and the accuracy of cures are changing the way diseases are pronounced and medicated, making it necessary to have a deep understanding of these complex changes. The marketing lawyers of the future must be outfitted to communicate the profit of these tailor-made situations to healthcare pros and navigate complicated experimental disputes. Additionally, the rise of mathematical health forms and telemedicine is changing the established buying model. As virtual interplays become more widespread, pharmaceutical demand counselors must become accustomed to doing business with healthcare professionals through mathematical channels. This demands an ability set that blends mechanics proficiency with productive ideas. Moreover, the emphasis on patient-in-the-middle care is a fluctuating administrative movement. The pharmaceutical reduction force of the future must not only use accompanying healthcare providers but also connect with conversant and enabled inmates. Building relationships with subjects and providing valuable news for further traditional device analyses will be critical for their benefit. In conclusion, the evolving healthcare landscape is changing the role of the drug sales force

Immunostimulants and Adaptogens from Plants Rehan Haider; Asghar Mehdi; Anjum Zehra; Geetha Kumari Das; Zameer Ahmed; Sambreen Zameer
International Journal of Scientific Multidisciplinary Research Vol. 2 No. 3 (2023): March 2024
Publisher : PT FORMOSA CENDEKIA GLOBAL

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55927/ijsmr.v2i3.8627

Immunostimulants and adaptogens from plants have acquired important consideration in recent times on account of their potential to reinforce the invulnerable system's response and advance overall prosperity. This study proposed to survey the different range of plant-derived compounds accompanying immunostimulant and adaptogenic characteristics, consider their systems of operation, and argue their potential therapeutic requests. An inclusive essay review was administered to recognize relevant studies and assemble a dossier on plant-located immunostimulants and adaptogens. Results disclosed a myriad of plant compounds, containing polysaccharides, polyphenols, alkaloids, and terpenoids, that exhibit immunostimulant properties by modulating miscellaneous invulnerable pathways. These compounds were erected to embellish the venture of immune containers, in the same way that macrophages, T cells, and everyday murderer cells reconstruct the corpse's armament against contamination and diseases. Furthermore, adaptogens, generally plants like Rhodiola rosea, Panax ginseng, and Withania somnifera, were proven to help the material suit stressors, both material and subjective. These adaptogenic compounds, to a degree saponins and withanolides, exercise their belongings through the hypothalamic-pituitary-adrenal (HPA) point around which something revolves and the regulation of stress birth control method levels. They lighten the damaging impact of incessant stress on the invulnerable system, advancing elasticity and overall fitness

The Challenges and Future of Advanced Therapies Rehan Haider; Asghar Mehdi; Anjum Zehra; Geetha Kumari Das; Zameer Ahmed
International Journal of Scientific Multidisciplinary Research Vol. 2 No. 4 (2024): April 2024
Publisher : PT FORMOSA CENDEKIA GLOBAL

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55927/ijsmr.v2i4.8628

Advanced therapies, including gene therapies, cell-based therapies, and tissue engineering, have emerged as revolutionary approaches in medicine. These therapies hold immense promise for treating previously un treatable diseases by targeting underlying causes at the molecular and cellular levels. However, their translation from laboratory breakthroughs to clinical applications is accompanied by significant challenges that must be addressed to realize their full potential. One major challenge lies in the complexity and variability of patient responses. The personalized nature of advanced therapies demands precise customization of each individual, necessitating the development of robust biomarkers and predictive models. Ensuring the safety of these therapies is paramount. Unforeseen immune reactions, off-target effects, and long-term consequences require stringent preclinical testing and vigilant post-market surveillance. Manufacturing scalability is another hurdle. Unlike traditional pharmaceuticals, advanced therapies often involve intricate processes specific to each patient. Standardizing and automating these processes, while maintaining product quality and consistency, are critical obstacles. Moreover, the high costs associated with research, development, manufacturing, and delivery hinder accessibility and affordability, raising concerns about equitable patient access. The regulatory landscape also requires adaptation to accommodate the unique attributes of advanced therapies. Striking a balance between timely access to patients and comprehensive evaluation of safety and efficacy challenges regulatory agencies globally. Intellectual property concerns, data sharing, and ethical considerations compounded these issues

Antibacterial Activity of Naturally Occurring Compounds from Selected Plants Rehan Haider; Asghar Mehdi; Anjum Zehra; Geetha Kumari Das; Zameer Ahmed
International Journal of Scientific Multidisciplinary Research Vol. 2 No. 4 (2024): April 2024
Publisher : PT FORMOSA CENDEKIA GLOBAL

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55927/ijsmr.v2i4.8630

The abstract presents a short survey of the study fact-finding the uncontaminated endeavor of normally occurring compounds derived from selected plants. This study investigated the potential of these compounds as uncontaminated powers in the field of unrefined brand-located drug discovery. The research complicated the distillation of bioactive compounds from a variety of plant beginnings famous for their curative properties. Therefore, these compounds were assigned to decontaminating assays against a range of bacterial strains by exploiting standard microbiological methods. The results revealed meaningful decontaminating activity of various compounds, signifying their potential as open opportunities for fighting bacterial contamination. Furthermore, this study delves into the systems latent the noticed completely clean belongings, peeling light on the biochemical pathways afflicted by these easily occurring compounds. This mechanistic intuitiveness embodies our understanding of the fashion of operation of compounds, which is critical for the occurrence of mean uncontaminated therapies. Additionally, this study debates the potential requests of these everyday compounds in drug and healthcare enterprises. The uncontaminated endeavor explained by these compounds desires their application for further growth and optimization, concreting the habit for novel healing mediations in the battle against bacterial contamination

Drug Development Research in Women Rehan Haider; Asghar Mehdi; Anjum Zehra; Geetha Kumari Das; Zameer Ahmed; Sambreen Zameer
International Journal of Scientific Multidisciplinary Research Vol. 2 No. 5 (2024): May 2024
Publisher : PT FORMOSA CENDEKIA GLOBAL

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55927/ijsmr.v2i5.8807

Drug research in wives is a critical district that has acquired growing consideration in recent ages. Historically, mothers have diminished in clinical tests, chief to a lack of understanding about in what way or manner drugs influence them otherwise distinguished to brothers. This information gap has important associations for drug security and efficiency, as physiological dissimilarities between genders can impact drug absorption, productiveness, and adverse belongings. In answer, skilled has existed a growing importance on containing girls in dispassionate trials and attending grammar principles that apply to nouns with sexual or animated connotations reasonings to guarantee that drugs are safe and persuasive for two together people interested in something. This paper provides an overview of the significance of containing mothers in drug-producing research. It discusses the classical circumstances of feminine bias in dispassionate trials and the supervisory changes that have been executed to address this issue. The paper again highlights the corporeal and hormonal distinctnesses middle from two points people that can influence drug responses. Furthermore, the paper tries to the challenges and space in drafting and maintaining women in dispassionate tests, containing righteous considerations and educational determinants

Human Monkeypox Epidemiologic and Clinical Characteristics, Diagnosis, and Prevention Rehan Haider; Asghar Mehdi; Anjum Zehra; Geetha Kumari Das
International Journal of Integrative Sciences Vol. 3 No. 3 (2024): March 2024
Publisher : PT FORMOSA CENDEKIA GLOBAL

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55927/ijis.v3i3.7337

Human monkeypox is a unique fervid disease caused by a monkeypox bacterium, an appendage of the Orthopoxvirus genus. Affliction exhibits epidemiological and dispassionate traits that pose challenges for disease and prevention. Primarily native to the Central and West African domains, monkeypox has gained worldwide attention because of occasional outbreaks and the potential for human-to-human broadcast. Epidemiologically, monkeypox shares similarities with smallpox, including reservoirs likely to contain rodents and non-human anthropoids. The virus may be transmitted to people through direct contact with infected mammals or bodily fluids. Person-to-person broadcasts, even though meager, contribute to the spread of ailments, stressing the need for active stopping strategies. Clinical evidence of human monkeypox includes delirium, problems, muscle aches, and a characteristic rash. The range of ailment asperity ranges from mild, self-confining cases to harsh forms accompanying obstacles, underscoring the importance of correct and appropriate diseases. However, distinguishing monkeypox from other rash ailments, including smallpox and chickenpox, is a challenge. The prevention of human monkeypox relies on early discovery and immunization. Surveillance works aim to monitor and contain outbreaks, whereas expeditious demonstrative tests influence up-to-the-minute case identification. Vaccination, accompanying the existing smallpox cure, has proven promising in preventing monkeypox and lowering the severity of the affliction. However, continuous research is crucial to evolving guide attacks, particularly given the disadvantages of the smallpox cure and the progressing type of virus

Corruption in the Pharmaceutical Sector Diagnosing the Challenges Rehan Haider; Asghar Mehdi; Anjum Zehra; Geetha Kumari Das; Zameer Ahmed
International Journal of Integrative Sciences Vol. 3 No. 3 (2024): March 2024
Publisher : PT FORMOSA CENDEKIA GLOBAL

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55927/ijis.v3i3.7728

Corruption inside the pharmaceutical industry is a pervasive and complicated problem that poses giant challenges to healthcare structures, public welfare, and ethical requirements. This abstract delves into the prognosis of the challenges posed by corruption in the pharmaceutical industry. The pharmaceutical sector performs a vital function in promoting international fitness by growing, generating, and distributing life-saving medicines. However, the arena is plagued by various kinds of corruption, such as bribery, fraud, kickbacks, and undue influence on regulatory procedures. This corruption leads to distorted priorities, compromised drug satisfaction, decreased access to important drug treatments, and expanded healthcare costs. One challenge is the complex web of relationships among pharmaceutical corporations, healthcare professionals, and regulatory governments. These relationships, while regularly critical for understanding trade and innovation, may be exploited for corrupt practices that prioritize income over patient well-being. Furthermore, inadequate regulation and susceptible enforcement mechanisms create an environment where corrupt activities can flourish

In Vitro Antioxidative Activity of some Medicinal Plants Rehan Haider; Asghar Mehdi; Anjum Zehra; Geetha Kumari Das; Zameer Ahmed; Sambreen Zameer
International Journal of Integrative Sciences Vol. 3 No. 4 (2024): April 2024
Publisher : PT FORMOSA CENDEKIA GLOBAL

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55927/ijis.v3i4.7999

The artificial antioxidative exercise of curative plants is a topic of meaningful interest on account of the potential healing benefits they concede they offer in fighting oxidative stress-related ailments. This study proposes to judge the antioxidant properties of picked medicinal plants using artificial assays. A range of plants famous for their established curative uses was chosen for inspection, containing [put plant names]. The methods complicated extracting bioactive compounds from the plant fabrics utilizing appropriate solvents and determining their antioxidative potential through miscellaneous assays such as DPPH radical scavenging endeavor, tough lowering antioxidant capacity (FRAP), and total phenolic content decision. These assays provide insights into the strength of the plant extracts to counteract free radicals and defeat oxidative damage. Results marked variable degrees of the antioxidative project between the proven plants, with a few exhibiting effective scavenging facilities against free radicals, while the remainder of something displayed notable phenolic content. These judgments underscore the variety of antioxidative means present in curative plants and desire their potential serviceability as natural beginnings of antioxidants for healing purposes

Nutraceuticals in Diabetes Management Rehan Haider; Asghar Mehdi; Anjum Zehra; Geetha Kumari Das; Zameer Ahmed
International Journal of Integrative Sciences Vol. 3 No. 4 (2024): April 2024
Publisher : PT FORMOSA CENDEKIA GLOBAL

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55927/ijis.v3i4.8158

Nutraceuticals, a suitcase of "food" and "pharmaceuticals," represent a blooming field in the administration of diabetes. With the all-encompassing predominance of diabetes reaching its disquieting dimensions, there is a growing need for complete approaches to complement normal analyses. Nutraceuticals, including bioactive compounds derived from snack beginnings, have attracted attention for their potential to prevent and treat diabetes.Polyphenols in various products, legumes, and teas have shown antagonistic diabetic properties by modulating sweet substance absorption and insulin sensitivity. curcumin fatty Curcumin, a bioactive compound in turmeric, demonstrates antagonistic-instigative and antioxidant properties, providing improved glycemic control. Omega-3 fatty acids, which are widespread in extricate oils, exhibit insulin-sensitizing properties and can diminish diabetic complexities. Additionally, dietary texture—a plethora of whole grains and legumes—aids the level of glucose in blood management and pressure administration. Nutraceuticals offer further glycemic control; however, they still address the associated problems of diabetes. Antioxidant-rich vitamins, such as C and E, protect against oxidative stress, which is involved in diabetic complications. insulin. Furthermore, certain minerals, to a certain degree chromium and magnesium, play crucial roles in insulin, indicating oxygen absorption

Modern Medicine and Pharmaceutics Rehan Haider; Asghar Mehdi; Anjum Zehra; Geetha Kumari Das; Zameer Ahmed; Sambreen Zameer
International Journal of Integrative Sciences Vol. 3 No. 4 (2024): April 2024
Publisher : PT FORMOSA CENDEKIA GLOBAL

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55927/ijis.v3i4.8225

Modern Medicine and pharmaceuticals have made tremendous strides in enhancing the healthcare and quality of life of people worldwide. This summary explores the key traits and trends in these fields. In recent decades, current medications have witnessed a paradigm shift toward personalized healthcare. Improvements in genomics, proteomics, and record analytics have paved the way for precision medication and tailoring treatments for an individual's genetic makeup. This technique enhances treatment efficacy while minimizing aspect consequences, marking a significant departure from the one-size-fits-all approach. Pharmaceutical research has experienced a revolution with the advent of biotechnology. Biopharmaceuticals, along with monoclonal antibodies and gene treatment plans, have emerged as powerful tools for the fight against formerly untreatable illnesses. Their ability to target specific molecules or genes has opened new frontiers in cancer treatment, uncommon illnesses, and autoimmune diseases. Furthermore, pharmaceutical enterprises have embraced virtual technologies. AI-pushed drug discovery, in silico medical trials, and telemedicine reshape the drug development pipeline and improve the care of affected persons. In particular, telemedicine has gained prominence, presenting available healthcare offerings and far-flung tracking. However, these advancements have moral and regulatory demands. Privateness issues, information protection, and equitable access to present-day remedies remain essential issues. The need for strong moral frameworks and regulatory oversight is paramount

Title

Found 10 Documents
Search

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Title Search

Found 10 Documents Search

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Title

Found 10 Documents
Search